Related references
Note: Only part of the references are listed.Cellular heterogeneity and plasticity in liver cancer
Lo -Kong Chan et al.
SEMINARS IN CANCER BIOLOGY (2022)
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer
Daniel J. Schaid et al.
EUROPEAN UROLOGY (2021)
Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Anna S. Nam et al.
NATURE REVIEWS GENETICS (2021)
DIGGER: exploring the functional role of alternative splicing in protein interactions
Zakaria Louadi et al.
NUCLEIC ACIDS RESEARCH (2021)
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches
Renumathy Dhanasekaran
SEMINARS IN LIVER DISEASE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains
Lijin K. Gopi et al.
NATURE COMMUNICATIONS (2021)
Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival
Andreas Schmidt et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
Soulaimane Aboulouard et al.
CELL REPORTS MEDICINE (2021)
Heterogeneity in mRNA Translation
Stijn Sonneveld et al.
TRENDS IN CELL BIOLOGY (2020)
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
Silvia Belluti et al.
CELLS (2020)
Roles and mechanisms of alternative splicing in cancer - implications for care
Sophie C. Bonnal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Quantification of translation uncovers the functions of the alternative transcriptome
Lorenzo Calviello et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation
Jian Zhang et al.
FRONTIERS IN GENETICS (2020)
Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin
Itay Cohen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
Honghai Ma et al.
SCIENTIFIC REPORTS (2019)
Clinical update on hypomethylating agents
Matthieu Duchmann et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Long-range enhancer-promoter contacts in gene expression control
Stefan Schoenfelder et al.
NATURE REVIEWS GENETICS (2019)
coMethDMR: accurate identification of co-methylated and differentially methylated regions in epigenome-wide association studies with continuous phenotypes
Lissette Gomez et al.
NUCLEIC ACIDS RESEARCH (2019)
A Pharmacogenomic Landscape in Human Liver Cancers
Zhixin Qiu et al.
CANCER CELL (2019)
A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters
Deniz Demircioglu et al.
CELL (2019)
RNA components of the spliceosome regulate tissue-and cancer-specific alternative splicing
Heidi Dvinge et al.
GENOME RESEARCH (2019)
Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors
Anchal Sharma et al.
CELL REPORTS (2019)
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
Fengju Chen et al.
NATURE COMMUNICATIONS (2019)
Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation
Yongsheng Li et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)
Genetic and transcriptional evolution alters cancer cell line drug response
Uri Ben-David et al.
NATURE (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
TMEM Proteins in Cancer: A Review
Kathleen Schmit et al.
FRONTIERS IN PHARMACOLOGY (2018)
Alternative splicing: the pledge, the turn, and the prestige. The key role of alternative splicing in human biological systems
L. M. Gallego-Paez et al.
HUMAN GENETICS (2017)
Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma
Bonan Lin et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease
Barbara E. Stranger et al.
NATURE GENETICS (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
FirebrowseR: an R client to the Broad Institute's Firehose Pipeline
Mario Deng et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2017)
PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast
Li Qian et al.
ONCOTARGET (2017)
Genome-Wide Association Analysis Identifies a GLUL Haplotype for Familial Hepatitis B Virus-Related Hepatocellular Carcinoma
You-Yu Lin et al.
CANCER (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Long non-coding RNA HNF1A-AS1 promotes hepatocellular carcinoma cell proliferation by repressing NKD1 and P21 expression
Cong Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages
Vignesh Ramesh et al.
GENE (2016)
NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma
Sheng Zhang et al.
TUMOR BIOLOGY (2016)
PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer
Ruiqiong Ma et al.
GYNECOLOGIC ONCOLOGY (2015)
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2
Carmen Ghilardi et al.
ONCOTARGET (2015)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
A novel transcript, VNN1-AB, as a biomarker for colorectal cancer
Marthe Lovf et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
PRSS3/mesotrypsin in prostate cancer progression: implications for translational medicine
Evette S. Radisky
ASIAN JOURNAL OF ANDROLOGY (2013)
Autocrine Extra-Pancreatic Trypsin 3 Secretion Promotes Cell Proliferation and Survival in Esophageal Adenocarcinoma
Song Han et al.
PLOS ONE (2013)
PRSS3 promotes tumour growth and metastasis of human pancreatic cancer
Guozhong Jiang et al.
GUT (2010)
Keratinocytes Synthesize Enteropeptidase and Multiple Forms of Trypsinogen during Terminal Differentiation
Jotaro Nakanishi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level
Julia Toth et al.
NEUROCHEMICAL RESEARCH (2007)
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer
Carmen J. Marsit et al.
CARCINOGENESIS (2007)
Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer
CJ Marsit et al.
MOLECULAR CARCINOGENESIS (2005)
Interchromosomal segmental duplications explain the unusual structure of PRSS3, the gene for an inhibitor-resistant trypsinogen
L Rowen et al.
MOLECULAR BIOLOGY AND EVOLUTION (2005)
Trypsin IV, a novel agonist of protease-activated receptors 2 and 4
GS Cottrell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
